AZN – astrazeneca plc - american depositary shares (US:NASDAQ)

News

AstraZeneca (NASDAQ:AZN) had its "sell" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.
What Makes AstraZeneca (AZN) a Strong Growing Company? [Yahoo! Finance]
AstraZeneca Spotlights 2025 Growth, 2026 Launch Wave and $80B 2030 Goal at JPM Conference [Yahoo! Finance]
Astrazeneca (AZN) Ascends While Market Falls: Some Facts to Note [Yahoo! Finance]
JPM26: AstraZeneca bids to accelerate oncology R&D with Modella AI acquisition [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com